Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
| ▸ | TACR1 | P25103 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 2/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | GRM5 | P41594 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22559199 | 0.84 | GPR119 (0.45) | SLC1A1TACR1DPP4 | |
| SCHEMBL20601128 | 0.76 | TEAD3 (0.46) | SLC1A1DPP4DPP7GRM5 | |
| SCHEMBL20601126 | 0.76 | TEAD3 (0.46) | SLC1A1DPP4DPP7GRM5 | |
| SCHEMBL18580070 | 0.75 | TACR1 (0.49) | SLC1A1TACR1CA1CA2CA7 | |
| Hydrochloric Acid SCHEMBL8817784 | 0.75 | TACR1 (0.49) | SLC1A1TACR1CA1CA2CA7 | |
| SCHEMBL21855171 | 0.75 | AGTR2 (0.51) | GRM5 | |
| SCHEMBL3580922 | 0.74 | GPR119 (0.56) | DPP4 | |
| SCHEMBL23274792 | 0.73 | ACHE (0.47) | — | |
| SCHEMBL2791945 | 0.72 | AGTR2 (0.53) | GRM5 | |
| SCHEMBL3580578 | 0.72 | TACR1 (0.46) | SLC1A1TACR1CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114072207-B | Bicyclic compounds | 维瓦斯治疗公司 | 2024-03-29 | — | — | CN | disclosed |